Recombinant CarA (UniProt ID: P99147) is expressed as a 366-amino acid polypeptide with a molecular weight of approximately 43 kDa . Key properties include:
| Property | Detail |
|---|---|
| Expression System | Yeast |
| Purification Tag | Polyhistidine (His tag) |
| Purity | >90% |
| Applications | ELISA, structural studies, enzymatic assays |
| Storage | Lyophilized in PBS (pH 7.4) with 50% glycerol; stable at -20°C or -80°C |
The protein retains functionality in its recombinant form, enabling studies on CPSase activity and bacterial metabolism .
Mutations in the pyr operon (regulated by pyrR), which interacts with CPSase products, alter S. aureus colonization and transmission dynamics . Inhibiting CarA could disrupt pyrimidine biosynthesis, offering a therapeutic target.
Carbamoyl phosphate synthesis is critical for S. aureus survival in nutrient-limited environments (e.g., host tissues). Studies show that metabolic adaptations in CPSase enhance bacterial persistence during infection .
Genetic Variability:
carA is highly conserved in S. aureus, but recombination events in metabolic genes (e.g., aroA) suggest adaptive evolution under host-specific pressures .
Colonization Fitness:
Mutations in pyrR (linked to CPSase regulation) improve gastrointestinal colonization in murine models, highlighting metabolic flexibility as a virulence factor .
The interaction between CarA and the large subunit (CarB) creates a heterodimeric enzyme with a sophisticated molecular tunnel system. In characterized bacterial CPS enzymes, this tunnel spans approximately 100 Angstroms and connects three separate active sites . The small subunit contains the glutaminase domain, while the large subunit contains two phosphorylation domains.
The molecular interface between the subunits is critical for:
Forming the ammonia tunnel that protects the reactive intermediate from the aqueous environment
Coordinating the multi-step reaction where ammonia produced by CarA must reach the carboxyphosphate intermediate in CarB
Enabling the allosteric regulation of glutaminase activity
These structural arrangements ensure that glutamine hydrolysis is coupled to carbamoyl phosphate formation, preventing wasteful glutamine consumption when the other substrates are unavailable.
Escherichia coli has been successfully used as an expression host for recombinant S. aureus proteins, including CarA . When expressing S. aureus CarA, several factors influence protein quality and yield:
For recombinant S. aureus CarA expression, the following parameters have proven effective:
Induction at lower temperatures (16-20°C) to improve protein solubility
Co-expression with chaperones if inclusion body formation is problematic
Purified recombinant CarA protein has been successfully used for applications including ELISA development .
Assessing CarA activity presents challenges since it normally functions as part of the CPS complex. Several approaches can be implemented:
Glutaminase Activity Assay: Measuring the hydrolysis of glutamine to glutamate independent of the complete CPS reaction.
Detection methods include:
Colorimetric detection of released ammonia using Nessler's reagent
Coupled enzyme assays that detect glutamate formation
Isotopic assays using labeled glutamine
Reconstitution Assays: Combining purified recombinant CarA with CarB to reconstitute full CPS activity.
Binding Studies: Assessing the interaction between CarA and CarB subunits.
Techniques include:
Surface plasmon resonance
Isothermal titration calorimetry
Pull-down assays using tagged proteins
When designing activity assays, it's important to include the necessary cofactors such as magnesium for ATP binding and potentially allosteric regulators that may enhance enzyme activity .
Based on available data for recombinant S. aureus proteins, including CarA, the following buffer conditions support protein stability and function:
For active enzyme preparations, additional considerations include:
Addition of reducing agents (DTT or β-mercaptoethanol) to maintain cysteine residues in reduced state
Inclusion of protease inhibitors to prevent degradation
Avoidance of repeated freeze-thaw cycles, which can significantly reduce enzymatic activity
Purification of recombinant S. aureus CarA can be optimized using the following multi-step approach:
Affinity Chromatography:
Secondary Purification:
Ion exchange chromatography based on CarA's theoretical pI
Size exclusion chromatography to remove aggregates and ensure homogeneity
Removal of His-tag using TEV or thrombin protease if tag interferes with activity studies
Quality Control Assessments:
The purification protocol should be designed to minimize time and maximize protein stability, as extended purification times can lead to protein degradation or loss of activity.
Multiple complementary approaches can be employed to characterize the CarA-CarB interaction:
Co-expression and Co-purification:
Co-express both subunits in E. coli with different tags
Use tandem affinity purification to isolate the complex
Analyze complex formation by size exclusion chromatography
Biophysical Characterization:
Surface plasmon resonance (SPR) to determine binding kinetics
Isothermal titration calorimetry (ITC) for thermodynamic parameters
Analytical ultracentrifugation to assess complex stoichiometry
Structural Biology Approaches:
Functional Studies:
Mutational analysis of predicted interface residues
Activity assays comparing individual subunits versus the complex
Cross-linking experiments to capture transient interactions
Understanding this interaction is crucial as the formation of the CarA-CarB complex is essential for the coordinated multi-step reaction and the formation of the ammonia tunnel that connects the active sites .
Based on knowledge from homologous enzymes, several targeted mutagenesis strategies can be employed:
Each mutant should be characterized through activity assays, stability measurements, and structural analyses to build a comprehensive understanding of structure-function relationships in S. aureus CarA.
S. aureus CarA represents a potential antimicrobial target due to several favorable characteristics:
Essential Metabolic Function:
CarA participates in the biosynthesis of pyrimidines and arginine, which are essential for bacterial survival
Inhibition would disrupt multiple metabolic pathways simultaneously
Structural Distinctions from Human Enzymes:
Bacterial CPS differs significantly from human carbamoyl phosphate synthetases
These differences could be exploited to develop selective inhibitors with minimal host toxicity
Target Validation Approaches:
Conditional knockout studies to confirm essentiality in S. aureus
Chemical genetics using partial inhibitors to validate vulnerability
Mouse infection models to demonstrate in vivo relevance
High-Throughput Screening Strategies:
Development of activity assays suitable for screening compound libraries
Virtual screening against the CarA structure or homology model
Fragment-based approaches to identify initial binding scaffolds
The unique molecular tunnel architecture and the requirement for CarA-CarB interaction present specific opportunities for inhibitor development that could disrupt either catalytic function or essential protein-protein interactions .
Multiple complementary techniques can be employed to determine the structure of S. aureus CarA:
X-ray Crystallography:
The gold standard for high-resolution protein structures
Critical considerations include:
Protein purity >95% with monodisperse behavior
Optimization of crystallization conditions
Co-crystallization with substrates or inhibitors to capture different conformational states
Cryo-electron Microscopy:
Increasingly powerful for medium to high-resolution structures
Particularly valuable for visualizing CarA in complex with CarB
Does not require protein crystallization, which can be challenging
NMR Spectroscopy:
Useful for studying protein dynamics and ligand interactions
May be limited by the size of CarA (~40 kDa)
Requires isotopically labeled protein
Computational Approaches:
A multi-technique approach would provide the most comprehensive structural understanding, capturing both static architectural features and dynamic conformational changes associated with catalysis and regulation.